Future Care Trading Company

9544XSAU

Saudi Exchange·Healthcare

SAR 1.76

▼︎ 0.56%(-0.01)

Live

Data as of 13 May 2026

Open

SAR 1.75

High

SAR 1.78

Low

SAR 1.75

Volume

547.0K

52W High

SAR 4.05

52W Low

SAR 1.51

-5.88%

-7.37%

-2.22%

-10.66%

YTD

-10.66%

-8.81%

Mīzān Analysis

42/60

High income with solid fundamentals

9544Sector

Market Cap

945.0M SAR

P/E

62.7

Revenue Growth

41.8%

Div Yield

72.16%

Rewards

No standout positive signals at current scores.

Risk Analysis

No significant risk flags at current scores.

Scores computed 13 May 2026

Fundamentals

Market Cap

945.0M SAR

P/E Ratio

62.67

P/B Ratio

10.39

EPS

SAR 0.03

EPS Growth

93.1%

Revenue

76.1M SAR

Revenue Growth

41.8%

Net Income

15.8M SAR

Profit Margin

20.7%

Debt / Assets

0.01

Dividend Yield

72.16%

Dividend Per Share

SAR 1.40

Shares Outstanding

500.0M

Reporting Period: 2025-12-31Data as of Apr 24, 2026

Mizān Summary

News

Sector News10Industry & macro context

Trade ministers discuss final steps for GCC-UK FTA

Qatar Tribune· 1 day agoNeutralEconomy

UAE launches global plan to reach 42 million people, eradicate river blindness by 2030

Economy Middle East· 3 days agoNeutral

UAE Business: PureHealth surpasses $1.72bn in local procurement spend

Gulf Daily News· 7 days agoEconomy

Bahrain SWF Mumtalakat, SandboxAQ to boost Bahrain’s biotech sector

MSN· 12 days agoNeutralEconomy

Abu Dhabi’s PureHealth Q1 2026 revenue rises 10 percent to $2 billion on global expansion

Economy Middle East· 13 days agoNeutral

Omani delegation visits China to explore high tech pharmaceutical and medical ventures

Times of Oman· 16 days agoNeutralEconomy

Memo to enhance training, employment in pharmaceutical industry inked

وكالة الانباء الاردنية· 23 days agoNeutralEconomy

Trump nominates Erica Schwartz as CDC director amid turmoil around leadership, vaccine policy

CNBC Business· 27 days agoNeutralMarket Movers

RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves

CNBC Business· 28 days agoPositiveMarket Movers

Hims & Hers stock jumps as U.S. moves forward with plan to reassess popular peptides

MarketWatch Top Stories· 28 days agoPositiveEconomy

Events

No upcoming corporate events